Safer Stress Tests for Myocardial Perfusion Imaging

Overview

Journal J Nucl Cardiol

Specialty Cardiology & Vascular Diseases

Date 2017 Oct 18

PMID 29039085

Citations 1

Authors

Sang-Geon Cho

Zeenat Jabin

Henry Hee-Seung Bom

Affiliations

Soon will be listed here.

Citing Articles

Review of cardiovascular imaging in the Journal of Nuclear Cardiology 2019: Single-photon emission computed tomography.

Hage F, AlJaroudi W J Nucl Cardiol. 2020; 27(4):1171-1179.

PMID: 32410057 DOI: 10.1007/s12350-020-02167-4.

References

Ross M, Wu E, Wilkins J, Gupta D, Shen S, Aulwes D . Safety and feasibility of adjunctive regadenoson injection at peak exercise during exercise myocardial perfusion imaging: The Both Exercise and Regadenoson Stress Test (BERST) trial. J Nucl Cardiol. 2013; 20(2):197-204. DOI: 10.1007/s12350-013-9679-1. View

Ghimire G, Hage F, Heo J, Iskandrian A . Regadenoson: a focused update. J Nucl Cardiol. 2012; 20(2):284-8. DOI: 10.1007/s12350-012-9661-3. View

Primeau M, Taillefer R, Essiambre R, Lambert R, Honos G . Technetium 99m SESTAMIBI myocardial perfusion imaging: comparison between treadmill, dipyridamole and trans-oesophageal atrial pacing "stress" tests in normal subjects. Eur J Nucl Med. 1991; 18(4):247-51. DOI: 10.1007/BF00186648. View

Elliott M, Holly T, Leonard S, Hendel R . Impact of an abbreviated adenosine protocol incorporating adjunctive treadmill exercise on adverse effects and image quality in patients undergoing stress myocardial perfusion imaging. J Nucl Cardiol. 2001; 7(6):584-9. DOI: 10.1067/mnc.2000.108737. View

Shryock J, Belardinelli L . Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology. Am J Cardiol. 1997; 79(12A):2-10. DOI: 10.1016/s0002-9149(97)00256-7. View

Johnson N, Gould K . Regadenoson versus dipyridamole hyperemia for cardiac PET imaging. JACC Cardiovasc Imaging. 2015; 8(4):438-447. DOI: 10.1016/j.jcmg.2014.11.016. View

Hsiao E, Ali B, Blankstein R, Skali H, Ali T, Bruyere Jr J . Detection of obstructive coronary artery disease using regadenoson stress and 82Rb PET/CT myocardial perfusion imaging. J Nucl Med. 2013; 54(10):1748-54. PMC: 4382359. DOI: 10.2967/jnumed.113.120063. View

Gould K, Lipscomb K, Hamilton G . Physiologic basis for assessing critical coronary stenosis. Instantaneous flow response and regional distribution during coronary hyperemia as measures of coronary flow reserve. Am J Cardiol. 1974; 33(1):87-94. DOI: 10.1016/0002-9149(74)90743-7. View

Thomas G, Cullom S, Kitt T, Feaheny K, Ananthasubramaniam K, Gropler R . The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without.... J Nucl Cardiol. 2017; 24(3):788-802. PMC: 5491644. DOI: 10.1007/s12350-017-0813-3. View

10.

Man W, Hu J, Zhao Z, Zhang M, Wang T, Lin J . Diagnostic performance of instantaneous wave-free ratio for the evaluation of coronary stenosis severity confirmed by fractional flow reserve: A PRISMA-compliant meta-analysis of randomized studies. Medicine (Baltimore). 2016; 95(36):e4774. PMC: 5023900. DOI: 10.1097/MD.0000000000004774. View

11.

Abdelmoneim S, Mulvagh S, Xie F, OLeary E, Adolphson M, Omer M . Regadenoson Stress Real-Time Myocardial Perfusion Echocardiography for Detection of Coronary Artery Disease: Feasibility and Accuracy of Two Different Ultrasound Contrast Agents. J Am Soc Echocardiogr. 2015; 28(12):1393-400. DOI: 10.1016/j.echo.2015.08.011. View

12.

Thompson R, Patil H, Thompson E, Thomas G, Al-Amoodi M, Kennedy K . Regadenoson pharmacologic stress for myocardial perfusion imaging: a three-way comparison between regadenoson administered at peak exercise, during walk recovery, or no-exercise. J Nucl Cardiol. 2012; 20(2):214-21. DOI: 10.1007/s12350-012-9660-4. View

13.

Vitola J, Brambatti J, CALIGARIS F, Lesse C, Nogueira P, Joaquim A . Exercise supplementation to dipyridamole prevents hypotension, improves electrocardiogram sensitivity, and increases heart-to-liver activity ratio on Tc-99m sestamibi imaging. J Nucl Cardiol. 2001; 8(6):652-9. DOI: 10.1067/mnc.2001.117204. View

14.

Kukovetz W, Holzmann S, Braida C, Poch G . Dual mechanism of the relaxing effect of nicorandil by stimulation of cyclic GMP formation and by hyperpolarization. J Cardiovasc Pharmacol. 1991; 17(4):627-33. DOI: 10.1097/00005344-199104000-00016. View

15.

Wu J, Yun J, Heller E, Dione D, Deman P, Liu Y . Limitations of dobutamine for enhancing flow heterogeneity in the presence of single coronary stenosis: implications for technetium-99m-sestamibi imaging. J Nucl Med. 1998; 39(3):417-25. View

16.

Cury R, Kitt T, Feaheny K, Blankstein R, Ghoshhajra B, Budoff M . A randomized, multicenter, multivendor study of myocardial perfusion imaging with regadenoson CT perfusion vs single photon emission CT. J Cardiovasc Comput Tomogr. 2015; 9(2):103-12.e1-2. DOI: 10.1016/j.jcct.2015.01.002. View

17.

Mahmarian J . Regadenoson stress during low-level exercise: The EXERRT trial-does it move the needle?. J Nucl Cardiol. 2017; 24(3):803-808. DOI: 10.1007/s12350-017-0873-4. View

18.

Buhr C, Gossl M, Erbel R, Eggebrecht H . Regadenoson in the detection of coronary artery disease. Vasc Health Risk Manag. 2008; 4(2):337-40. PMC: 2496979. DOI: 10.2147/vhrm.s1798. View

19.

Kwon D, Cerqueira M, Young R, Houghtaling P, Lieber E, Menon V . Lessons from regadenoson and low-level treadmill/regadenoson myocardial perfusion imaging: initial clinical experience in 1263 patients. J Nucl Cardiol. 2010; 17(5):853-7. DOI: 10.1007/s12350-010-9229-z. View

20.

Lee J, Kato D, Oi M, Toyofuku M, Takashima H, Waseda K . Safety and efficacy of intracoronary nicorandil as hyperaemic agent for invasive physiological assessment: a patient-level pooled analysis. EuroIntervention. 2016; 12(2):e208-15. DOI: 10.4244/EIJV12I2A34. View